Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

We are glad that Isomorphic is helping advance the field and are able to match the level of performance we demonstrated at the ARDD conference in Copenhagen last August. In August, Deep Origin ...

Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the company said on Monday. Thrive Capital, a venture capital firm, led the ...

Isomorphic Labs, launched in 2021 with Google DeepMind, unveiled its newest joint AI offering AlphaFold 3, an AI model that was developed by Isomorphic Labs and Google DeepMind. According to ...

Add Yahoo as a preferred source to see more of our stories on Google. Demis Hassabis speaks during the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 20, 2026.

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

The most visible impact of AI seems to be in coding, but it could also be poised to disrupt other hard sciences.

London-based Isomorphic Labs Ltd., a drug discovery-focused artificial intelligence startup that was spun out of Google LLC’s DeepMind unit just over two years ago, today announced key partnerships ...